ArticleJournal of thoracic disease2018

How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.

Yalei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.